The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma

The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD)

(2016) Christopher Kingswood et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands

(2015) Marinus J.C. Eijkemans et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial

(2015) John J. Bissler et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex

(2014) Jeng-Dau Tsai et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study

(2014) David Neal Franz et al.   LANCET ONCOLOGY

The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1

(2014) J. C. Kingswood et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

(2013) John J Bissler et al.   LANCET

Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action

(2013) Y. Pirson   NEPHROLOGY DIALYSIS TRANSPLANTATION

Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma

(2013) D. A. Krueger et al.   NEUROLOGY

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

(2012) David Neal Franz et al.   LANCET

Tuberous Sclerosis Complex–Associated Angiomyolipomas: Focus on mTOR Inhibition

(2011) Klemens Budde et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Tuberous Sclerosis Complex: Neurological, Renal and Pulmonary Manifestations

(2011) D. N. Franz et al.   NEUROPEDIATRICS

Tuberous sclerosis complex: tumors and tumorigenesis

(2010) Julita Borkowska et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

(2010) Darcy A. Krueger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Perinatal (Fetal and Neonatal) Tuberous Sclerosis: A Review

(2009) Hart Isaacs   AMERICAN JOURNAL OF PERINATOLOGY

Effect of topiramate on acid-base balance: extent, mechanism and effects

(2009) Nasir Mirza et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature

(2009) M. E. A. P. M. Adriaensen et al.   EUROPEAN JOURNAL OF NEUROLOGY

New Equations to Estimate GFR in Children with CKD

(2009) G. J. Schwartz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

(2008) Jingxiang Huang et al.   BIOCHEMICAL JOURNAL